The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Forecasted Market Value Of The Leukotriene Modifiers Market Across 2026–2030?
The leukotriene modifiers market size has seen strong growth in recent years. It is projected to increase from $23.54 billion in 2025 to $24.92 billion in 2026, at a compound annual growth rate (CAGR) of 5.9%. This past growth can be attributed to the high prevalence of asthma and allergic rhinitis, the established clinical efficacy of montelukast and related drugs, a preference for non-steroidal asthma therapies, significant adoption in pediatric asthma management, and the availability of multiple oral dosage forms.
The leukotriene modifiers market size is poised for robust expansion in the upcoming years. It is projected to reach $30.63 billion in 2030, driven by a compound annual growth rate (CAGR) of 5.3%. This growth during the forecast period can be attributed to the rising global incidence of respiratory and allergic illnesses, improved diagnosis rates for asthma and rhinitis, an increasing demand for convenient oral treatments, the broadening reach of generic drugs, and enhanced access to respiratory care in emerging markets. Significant trends expected in the forecast period include the sustained application of leukotriene modifiers in asthma maintenance regimens, a growing preference for oral and pediatric-appropriate formulations, an expanding role for leukotriene modifiers in the management of allergic rhinitis, the widespread availability of generic leukotriene modifier medications, and their use as an add-on therapy in conjunction with inhaled corticosteroids.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16109&type=smp
What Drivers Are Shaping The Future Growth Of The Leukotriene Modifiers Market?
The leukotriene modifier market is expected to experience growth driven by the rising prevalence of asthma and allergic conditions. These disorders involve an overreaction of the immune system to allergens, leading to inflammation, constricted airways, and various respiratory symptoms. The increased incidence of asthma and allergic conditions is attributed to greater exposure to pollutants, escalating temperatures, evolving weather patterns, and higher population densities. The leukotriene modifier market supports respiratory health by offering treatments that reduce inflammation, enhance airway function, and assist in managing symptoms associated with asthma and allergic conditions. For example, in October 2024, the National Asthma Council, an Australia-based non-profit organization, reported that Australia recorded 474 asthma-related deaths in 2023, consisting of 325 females and 149 males. This total is almost identical to the 473 asthma-related deaths documented in 2022, indicating a consistent trend in asthma mortality over these two years. Consequently, the increasing occurrence of asthma and allergic conditions is a primary factor fueling the expansion of the leukotriene modifier market.
What Segmentation Levels Are Considered In The Leukotriene Modifiers Market?
The leukotriene modifiers market covered in this report is segmented –
1) By Drug Type: Montelukast, Zafirlukast, Zileuton ER, Zileuton
2) By Form: Tablets, Chewable Tablets, Oral Granules
3) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies
What Trends Are Projected To Affect The Leukotriene Modifiers Market?
Major companies operating in the leukotriene modifier market are concentrating on developing generic extended-release (ER) formulations to expand treatment possibilities, enhance dosing ease, and satisfy the growing patient need for long-acting respiratory therapies. Generic extended-release tablets refer to pharmaceutical preparations designed to progressively release the active ingredient over an extended duration, which aids in maintaining consistent therapeutic concentrations, reducing dosing frequency, and improving patient adherence when compared to immediate-release versions. For instance, in April 2023, Camber Pharmaceuticals Inc., a US-based pharmaceutical company, incorporated Zileuton ER Tablets into its product offerings, providing a 600 mg extended-release formulation indicated for the prevention and long-term management of asthma in adults and adolescents aged 12 years and older, ensuring sustained therapeutic coverage while supporting continued administration during acute asthma exacerbations.
Which Leading Firms Are Contributing To The Growth Of The Leukotriene Modifiers Market?
Major companies operating in the leukotriene modifiers market are Merck And Co., AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Hetero Drugs Limited, Sun Pharmaceutical Industries, Sumitomo Dainippon Pharma, Cipla Limited, Aurobindo Pharma Limited, Dr. Reddy’s Laboratories, Apotex Pharmaceutical Holdings Inc., Torrent Pharmaceuticals Ltd., DAVA Pharmaceuticals, Alembic Pharmaceuticals Ltd., Lannett Company, Accord Healthcare, Jubilant Life Sciences Ltd., Aytu BioScience
Read the full leukotriene modifiers market report here:
https://www.thebusinessresearchcompany.com/report/leukotriene-modifiers-global-market-report
Which Geographic Regions Are Influencing Demand In The Leukotriene Modifiers Market?
North America was the largest region in the leukotriene modifiers market in 2025. The regions covered in the leukotriene modifiers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Leukotriene Modifiers Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=16109&type=smp
Browse Through More Reports Similar to the Global Leukotriene Modifiers Market 2026, By The Business Research Company
Leukotriene Modifiers Market Report 2026
https://www.thebusinessresearchcompany.com/report/leukotriene-modifiers-global-market-report
Rheology Modifiers Market Report 2026
https://www.thebusinessresearchcompany.com/report/rheology-modifiers-global-market-report
Liraglutide And Semaglutide Market Report 2026
https://www.thebusinessresearchcompany.com/report/liraglutide-and-semaglutide-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model